PDB Short entry for 1BA6 HEADER GLYCOPROTEIN 22-APR-98 1BA6 TITLE SOLUTION STRUCTURE OF THE METHIONINE-OXIDIZED AMYLOID BETA-PEPTIDE (1- TITLE 2 40). DOES OXIDATION AFFECT CONFORMATIONAL SWITCHING? NMR, 10 TITLE 3 STRUCTURES COMPND MOL_ID: 1; COMPND 2 MOLECULE: AMYLOID BETA-PEPTIDE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: ABETA; COMPND 5 ENGINEERED: YES; COMPND 6 MUTATION: YES; COMPND 7 OTHER_DETAILS: METHIONINE OXIDIZED SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: UNIDENTIFIED; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 32644 KEYWDS GLYCOPROTEIN, OXIDIZED AMYLOID BETA-PEPTIDE, ALZHEIMER'S DISEASE, KEYWDS 2 METHIONINE SULFOXIDE EXPDTA SOLUTION NMR NUMMDL 10 AUTHOR A.A.WATSON,D.P.FAIRLIE,D.J.CRAIK REVDAT 3 16-FEB-22 1BA6 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 1BA6 1 VERSN REVDAT 1 17-JUN-98 1BA6 0 JRNL AUTH A.A.WATSON,D.P.FAIRLIE,D.J.CRAIK JRNL TITL SOLUTION STRUCTURE OF METHIONINE-OXIDIZED AMYLOID JRNL TITL 2 BETA-PEPTIDE (1-40). DOES OXIDATION AFFECT CONFORMATIONAL JRNL TITL 3 SWITCHING? JRNL REF BIOCHEMISTRY V. 37 12700 1998 JRNL REFN ISSN 0006-2960 JRNL PMID 9737846 JRNL DOI 10.1021/BI9810757 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: REFINEMENT DETAILS CAN BE FOUND IN REMARK 3 JOURNAL CITATION ABOVE. REMARK 4 REMARK 4 1BA6 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000171515. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 5.3 REMARK 210 IONIC STRENGTH : NULL REMARK 210 PRESSURE : NULL REMARK 210 SAMPLE CONTENTS : NULL REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : NOESY; TOCSY REMARK 210 SPECTROMETER FIELD STRENGTH : 500 MHZ; 750 MHZ REMARK 210 SPECTROMETER MODEL : AMX-500; DRX-750 REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : X-PLOR REMARK 210 METHOD USED : SIMULATED ANNEALING USING NOE REMARK 210 DISTANCE CONSTRAINTS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 50 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 10 REMARK 210 CONFORMERS, SELECTION CRITERIA : LOW ENERGY, LOW VIOLATIONS REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : NULL REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 GLU A 3 38.87 -89.12 REMARK 500 1 HIS A 6 33.09 -81.60 REMARK 500 1 SER A 8 -169.90 -65.85 REMARK 500 1 HIS A 14 46.23 -100.89 REMARK 500 1 PHE A 20 -8.72 -49.60 REMARK 500 1 SER A 26 40.22 -92.29 REMARK 500 1 ASN A 27 150.05 -48.65 REMARK 500 1 LYS A 28 43.09 -163.74 REMARK 500 1 SME A 35 32.71 -165.39 REMARK 500 1 VAL A 39 34.24 -97.14 REMARK 500 2 ALA A 2 62.83 -170.44 REMARK 500 2 HIS A 6 37.87 38.97 REMARK 500 2 ASP A 7 98.17 -49.02 REMARK 500 2 SER A 8 39.20 -168.30 REMARK 500 2 TYR A 10 51.89 -102.24 REMARK 500 2 HIS A 14 85.03 -56.97 REMARK 500 2 LYS A 16 14.90 55.53 REMARK 500 2 PHE A 20 -17.73 -46.95 REMARK 500 2 SER A 26 32.49 -82.05 REMARK 500 2 LYS A 28 40.57 -165.26 REMARK 500 2 ALA A 30 -45.30 -134.90 REMARK 500 3 ARG A 5 -118.80 -83.90 REMARK 500 3 HIS A 6 64.78 18.35 REMARK 500 3 ASP A 7 94.42 -64.30 REMARK 500 3 TYR A 10 57.36 -99.78 REMARK 500 3 GLU A 11 -68.09 -161.11 REMARK 500 3 HIS A 14 37.60 -87.11 REMARK 500 3 GLN A 15 -86.40 -135.88 REMARK 500 3 SER A 26 52.64 -94.21 REMARK 500 3 LYS A 28 42.05 -165.95 REMARK 500 3 ALA A 30 -46.53 -161.51 REMARK 500 3 LEU A 34 35.04 34.36 REMARK 500 3 VAL A 39 33.82 -97.99 REMARK 500 4 ALA A 2 66.79 -161.72 REMARK 500 4 GLU A 3 78.93 35.33 REMARK 500 4 SER A 8 124.02 67.14 REMARK 500 4 TYR A 10 -11.97 -147.86 REMARK 500 4 GLU A 11 20.02 -78.33 REMARK 500 4 VAL A 12 -178.25 -68.65 REMARK 500 4 HIS A 13 47.29 -106.97 REMARK 500 4 HIS A 14 91.26 -47.53 REMARK 500 4 GLN A 15 -47.64 -179.57 REMARK 500 4 PHE A 20 -16.06 -48.57 REMARK 500 4 LEU A 34 101.56 -165.50 REMARK 500 5 ALA A 2 105.85 -172.00 REMARK 500 5 ARG A 5 53.18 -169.68 REMARK 500 5 VAL A 12 173.88 -59.74 REMARK 500 5 HIS A 13 55.87 -141.36 REMARK 500 5 GLN A 15 -118.82 -91.63 REMARK 500 5 PHE A 20 -19.17 -46.45 REMARK 500 REMARK 500 THIS ENTRY HAS 100 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 1BA6 A 1 40 UNP P05067 A4_HUMAN 672 711 SEQADV 1BA6 SME A 35 UNP P05067 MET 706 MODIFIED RESIDUE SEQRES 1 A 40 ASP ALA GLU PHE ARG HIS ASP SER GLY TYR GLU VAL HIS SEQRES 2 A 40 HIS GLN LYS LEU VAL PHE PHE ALA GLU ASP VAL GLY SER SEQRES 3 A 40 ASN LYS GLY ALA ILE ILE GLY LEU SME VAL GLY GLY VAL SEQRES 4 A 40 VAL MODRES 1BA6 SME A 35 MET METHIONINE SULFOXIDE HET SME A 35 18 HETNAM SME METHIONINE SULFOXIDE FORMUL 1 SME C5 H11 N O3 S HELIX 1 1 GLN A 15 GLY A 25 1 11 LINK C LEU A 34 N SME A 35 1555 1555 1.31 LINK C SME A 35 N VAL A 36 1555 1555 1.31 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000